The Process Step 1: Beginning with an initial consultation to determine your eligibility, our team of experienced medical experts will conduct a comprehensive assessment, including a physical, blood work, and body fat composition analysis
GLP-1RA medications are the first pharmacotherapy for obesity with demonstrable cardiovascular benefits and ASCVD risk reduction
Injection timing is typically 30-60 minutes after training on workout days
The trade-off is that higher water volume can slightly accelerate peptide degradation over the 28-day refrigerated window, though the effect is marginal if stored at 28C consistently
By contrast, multi-ingredient formulas can make it harder to determine which ingredient is responsible for a particular outcome
If a patient is constantly nauseated, unable to eat properly, or feeling unwell, the medication may no longer be the right tool